Updated August 14, 2026 · Quality Verification · CoA Library
Short answer: Percent purity and quantitative assay are not interchangeable. Percent purity describes how dominant the primary detected component is relative to other detected components under a stated analytical method. Quantitative assay estimates how much target material is present in the submitted sample. A complete research documentation review should consider both results.
This distinction matters because a strong-looking purity percentage can be misunderstood as proof that a vial contains the full nominal amount. It does not answer that question by itself. Purity addresses composition under the method; assay addresses measured quantity.
What percent purity means
In research peptide documentation, percent purity is often reported from a chromatographic analysis. The laboratory separates detectable components and reports the primary component as a percentage of the relevant detected signal under the method used.
For example, a high reported purity can indicate that the primary detected component dominates the chromatogram. It does not automatically establish the exact mass of target material in the sample, the identity of every minor component, or the results of tests that were not performed.
The method, integration approach, reporting threshold, and sample preparation all provide context. The complete report should remain the controlling source.
What quantitative assay means
Quantitative assay estimates the amount of target material measured in the submitted sample. Depending on the laboratory and method, the result may be expressed as mass, concentration, a percentage of a nominal claim, or another defined unit.
Assay is the measurement to review when the question is whether the submitted sample contains an amount consistent with the represented quantity. Units are critical. A result should not be compared with a label until the reviewer confirms what was measured, how it was calculated, and whether the sample basis is comparable.
Purity and assay side by side
| Measurement | Question answered | Typical review focus |
|---|---|---|
| Percent purity | How dominant is the primary detected component? | Chromatographic method, peaks, integration, and reported percentage |
| Quantitative assay | How much target material was measured? | Amount, concentration, units, calibration, and comparison basis |
| Identity test | Is the sample consistent with the represented compound? | Method, expected signal or mass, and laboratory conclusion |
These results complement one another. They should not be collapsed into a single generic “quality” number.
Why a high purity result can coexist with a different assay result
Purity is generally a relative composition result under the analytical method, while assay is a quantity result. A sample can show a high proportion of the primary detected component and still have a measured amount that differs from the nominal quantity. That does not make the two results contradictory; they are evaluating different characteristics.
Several factors can affect how a quantitative result is reported, including sample preparation, moisture or counterion considerations, calibration, reference standards, and the laboratory’s calculation basis. Reviewers should use the explanation and units provided on the report rather than trying to reverse-engineer a result from the purity percentage.
A practical documentation review sequence
- Verify identity. Confirm that the report includes an appropriate identity result for the represented compound.
- Match the lot. Connect the CoA to the exact batch or lot being reviewed.
- Read the purity result. Note the method, reported percentage, and any qualifiers.
- Read the assay result. Confirm the amount, units, comparison basis, and any stated uncertainty or qualifier.
- Review screening separately. Heavy-metal, microbial, and other tests answer additional questions and should not be inferred from purity or assay.
- Resolve gaps. Ask for clarification when pages, units, lot numbers, or report status are unclear.
The research peptide CoA review guide walks through the complete document in order, while the Primeva Labs quality verification page explains the broader documentation framework.
What neither result proves alone
Neither percent purity nor quantitative assay establishes every quality attribute. They do not independently prove sterility, the absence of all possible contaminants, stability under every storage condition, or suitability for a particular laboratory model. Those questions require their own methods, specifications, controls, or research judgment.
They also do not establish clinical safety, therapeutic effectiveness, dosing, or suitability for human or animal use. Research-use classification and analytical documentation address different issues.
How to compare reports from different laboratories
Results from different laboratories may not be directly interchangeable when the methods, instruments, calculations, sample preparation, or reporting conventions differ. Before comparing headline values, check whether both reports use the same type of analysis and comparable units.
A responsible comparison asks:
- Were the same analytical questions tested?
- Are the methods and sample preparations comparable?
- Do the reports define purity and assay the same way?
- Are the units and calculation basis aligned?
- Do both documents apply to the batches being compared?
This is one reason Primeva Labs emphasizes batch-specific records rather than relying on a generic supplier claim. Researchers can inspect available documents in the CoA library and use the research comparison guide to keep product and documentation questions separate.
Common interpretation errors
“99 percent purity means the vial contains 99 percent of the labeled amount”
Not necessarily. A purity percentage and the quantity represented on a label use different comparison bases. Review the assay result for measured amount.
“A passing assay makes identity testing unnecessary”
No. Quantity is meaningful only when the material being quantified has been appropriately identified under the testing framework.
“One strong result proves the complete quality profile”
No single result answers every question. Identity, purity, assay, screening, batch traceability, and report status each contribute separate evidence.
The better question to ask
Instead of asking whether a research peptide has a “good CoA,” ask whether the report clearly answers the analytical questions relevant to procurement: what material was tested, which batch it represents, whether identity was confirmed, how purity was measured, how much target material was found, and which additional screens were performed.
Use the research category guide to narrow catalog sections, then review the product specifications and applicable batch documentation before selecting materials for a defined laboratory model.
Research-use notice: Primeva Labs products are sold strictly for laboratory and research use only. They are not for human or animal consumption and are not intended to diagnose, treat, cure, or prevent any disease.